Okemoto et al.: oHSV and Demethylating Agents
نویسندگان
چکیده
Dardinger Center for Neuro-oncology and Neurosciences, Department of Neurological Surgery, N-1017 Doan Hall, 410 W. 10 Avenue, James Cancer Hospital/Solove Research Institute/Comprehensive Cancer Center and Wexner Medical Center, and 2 Center for Biostatistics, The Ohio State University, Columbus, OH 43210-1240 Department of Neurosurgery Institute for the Neurosciences at the Brigham, Brigham and Women's/ Faulkner Hospital and Center for Neuro-oncology, Dana-Farber Cancer Institute, 75 Francis Street, Boston, MA 02116 Phone: 617-732-7496, Fax: 617-734-8342 Email: [email protected]
منابع مشابه
STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells
Recent studies report that STAT3 signaling is a master regulator of mesenchymal transformation of gliomas and that STAT3 modulated genes are highly expressed in the mesenchymal transcriptome of gliomas. A currently studied experimental treatment for gliomas consists of intratumoral injection of oncolytic viruses (OV), such as oncolytic herpes simplex virus type 1 (oHSV). We have described one p...
متن کاملDNA demethylating agents synergize with oncolytic HSV1 against malignant gliomas.
PURPOSE Oncolytic viruses (OV) based on herpes simplex virus type 1 (HSV1) are being used in clinical trials for a variety of cancers. The OV, rQNestin34.5, uses a nestin promoter/enhancer to selectively drive robust viral replication in malignant glioma cells. We have discovered that this promoter becomes extensively methylated in infected glioma cells, reducing OV efficacy. EXPERIMENTAL DES...
متن کاملHistone deacetylase 6 inhibition enhances oncolytic viral replication in glioma.
Oncolytic viral (OV) therapy, which uses genetically engineered tumor-targeting viruses, is being increasingly used in cancer clinical trials due to the direct cytolytic effects of this treatment that appear to provoke a robust immune response against the tumor. As OVs enter tumor cells, intrinsic host defenses have the potential to hinder viral replication and spread within the tumor mass. In ...
متن کاملCancer Therapy: Preclinical DNA Demethylating Agents Synergize with Oncolytic HSV1 against Malignant Gliomas
Purpose:Oncolytic viruses (OV) based on herpes simplex virus type 1 (HSV1) are being used in clinical trials for a variety of cancers. The OV, rQNestin34.5, uses a nestin promoter/enhancer to selectively drive robust viral replication in malignant glioma cells. We have discovered that this promoter becomes extensively methylated in infected glioma cells, reducing OV efficacy. ExperimentalDesign...
متن کاملOncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
Oncolytic viruses (OV) are a class of antitumor agents that selectively kill tumor cells while sparing normal cells. Oncolytic herpes simplex virus (oHSV) has been investigated in clinical trials for patients with the malignant brain tumor glioblastoma for more than a decade. These clinical studies have shown the safety of oHSV administration to the human brain, however, therapeutic efficacy of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2013